Related references
Note: Only part of the references are listed.Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study
Dorian Culie et al.
EUROPEAN JOURNAL OF CANCER (2021)
Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers
Paul Giraud et al.
CANCERS (2021)
Artificial Intelligence-based methods in head and neck cancer diagnosis: an overview
Hanya Mahmood et al.
BRITISH JOURNAL OF CANCER (2021)
Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients
Arta Hoesseini et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma
Linyan Chen et al.
CANCER MEDICINE (2021)
Head and neck cancer
Mayur D. Mody et al.
LANCET (2021)
Head and Neck Cancers, Version 2.2020
David G. Pfister et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions
Elaine O. Bigelow et al.
ORAL ONCOLOGY (2020)
Role of salivary transcriptomics as potential biomarkers in oral cancer: A systematic review
Shankargouda Patil et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
Prevalence and characteristics of HPV-driven oropharyngeal cancer in France
Haitham Mirghani et al.
CANCER EPIDEMIOLOGY (2019)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Smoking impact on HPV driven head and neck cancer's oncological outcomes?
Haitham Mirghani et al.
ORAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
Haitham Mirghani et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2018)
Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status
Dan Ou et al.
ORAL ONCOLOGY (2017)
Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: is it an underestimated phenomenon? A radiation oncologist's perspective
J. Cacicedo et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2015)
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma
Maura L. Gillison et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)
Pirus Ghadjar et al.
RADIATION ONCOLOGY (2015)
Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
Chintan Parmar et al.
FRONTIERS IN ONCOLOGY (2015)
Global burden of human papillomavirus-positive head and neck cancers
Anil K. Chaturvedi
LANCET ONCOLOGY (2014)
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Share Paper
